Core Viewpoint - IBM is expected to report a profit increase in its upcoming fiscal Q1 earnings announcement, reflecting positive growth trends in its financial performance [2][3]. Financial Performance - IBM's market capitalization stands at $226.4 billion [1]. - Analysts predict a profit of $1.78 per share for Q1 of fiscal 2026, which is an 11.3% increase from $1.60 per share in the same quarter last year [2]. - For the current fiscal year ending in December, the expected profit is $12.37 per share, up 6.7% from $11.59 per share in fiscal 2025 [3]. - EPS is projected to grow 7.5% year-over-year to $13.30 in fiscal 2027 [3]. Earnings History - IBM has consistently surpassed Wall Street's bottom-line estimates in the last four quarters [2]. - The earnings surprises for the previous quarters are as follows: - Q1: Reported $1.60 vs. Estimate $1.42 (+12.68%) - Q2: Reported $2.80 vs. Estimate $2.64 (+6.07%) - Q3: Reported $2.65 vs. Estimate $2.44 (+8.61%) - Q4: Reported $4.52 vs. Estimate $4.33 (+4.39%) [4]. Stock Performance - Over the past 52 weeks, IBM shares have decreased by 3.5%, underperforming the S&P 500 Index's 13.4% return and the State Street Technology Select Sector SPDR ETF's 24.1% increase [4]. Strategic Moves - IBM's acquisition of Confluent aims to enhance its AI and data capabilities, creating a unified, real-time data platform to support AI-driven applications [5]. Analyst Ratings - Wall Street analysts maintain a "Moderate Buy" rating for IBM, with a mean price target of $313.90, indicating a 29.9% premium to its current price levels [6].

Core Viewpoint - The article emphasizes the importance of generating alpha through independent investment strategies, focusing on a generalist approach across various sectors with potential for outperforming the S&P 500 [1] Group 1: Investment Strategy - The company manages a family portfolio primarily through a Self Managed Super Fund, aiming for a holding period that ranges from a few quarters to multiple years [1] - The investment approach includes building and maintaining spreadsheets that track historical financial data, key metrics, guidance trends, and performance indicators [1] - The company prefers assessing past performance and broad outlooks on key drivers of valuation rather than projecting long-term financials through DCF models [1] Group 2: Research Methodology - The research process involves monitoring industry news, reports, and other analysts' coverage, particularly during significant events like CEO changes [1] - The company conducts reverse DCF analyses for firms trading at high multiples to understand implied growth rates [1] - Key drivers of DCF valuation considered include revenues, costs and margins, cash flow conversion, capital expenditures, and interest rates [1]

Core Viewpoint - IBM is expected to report strong earnings growth in its upcoming fiscal Q4 2025 earnings announcement, with analysts projecting a profit increase of 10.5% year-over-year, reflecting the company's consistent performance in surpassing Wall Street estimates [2][3]. Financial Performance - Analysts anticipate IBM will report a profit of $4.33 per share for Q4 2025, up from $3.92 per share in the same quarter last year, marking a 10.5% increase [2]. - For the current fiscal year ending in December, IBM is expected to report a profit of $11.39 per share, which is a 10.3% increase from $10.33 per share in fiscal 2024 [3]. - The company's EPS is projected to grow 7.5% year-over-year to $12.24 in fiscal 2026 [3]. Stock Performance - Over the past 52 weeks, IBM's stock has surged 34.6%, outperforming the S&P 500 Index's return of 16.2% and the State Street Technology Select Sector SPDR ETF's increase of 25.2% [4]. - On November 12, shares of IBM rose by 2% following the announcement of significant advancements in quantum computing, specifically the unveiling of the IBM Quantum Nighthawk processor [5]. Analyst Ratings - Wall Street analysts maintain a "Moderate Buy" rating for IBM, with 22 analysts covering the stock: nine recommend "Strong Buy," one suggests "Moderate Buy," ten advise "Hold," and two recommend "Strong Sell" [6]. - Although IBM is currently trading above its mean price target of $291.05, the highest price target of $360 indicates a potential upside of 19.8% from current levels [6].